Search clinical trials for: Adaptive Androgen Deprivation Therapy (ADT)
Total 808 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruiting
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
Washington University School of MedicineVarian Medical SystemsRecruitingProstate Cancer | Cancer of the ProstateUnited States
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCNot yet recruitingProstate Cancer | Prostatectomy | Androgen Axis SuppressionUnited States
-
European Institute of OncologyRecruitingOligometastatic Prostate CancerItaly
-
VA Greater Los Angeles Healthcare SystemActive, not recruiting
-
University of CincinnatiJanssen, LPRecruitingProstate CancerUnited States
-
Janssen Research & Development, LLCRecruitingMetastatic Castrate-sensitive Prostate CancerUnited States, France, Mexico, Germany, Australia, Brazil, Canada, China, Poland
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Xian-Janssen Pharmaceutical Ltd.Not yet recruitingProstate Cancer | Biochemical Recurrence | High RiskChina
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Recruiting
-
Istituto Clinico HumanitasRecruitingOligorecurrent and Oligoprogressive Prostate Cancer PatientsItaly
-
Changhai HospitalRecruiting
-
Advocate Health CareRecruitingProstate AdenocarcinomaUnited States
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Jiangsu HengRui Medicine Co., Ltd.RecruitingProstate Cancer | Biochemical RecurrenceChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...First Affiliated Hospital of Zhejiang University; The First Affiliated Hospital...Recruiting
-
BayerRecruiting
-
BayerOrion Corporation, Orion PharmaActive, not recruitingDarolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer (ARANOTE)Prostatic NeoplasmsChina, Russian Federation, Taiwan, Latvia, India, Australia, Brazil, Canada, Chile, Lithuania, New Zealand, Peru, South Africa, Spain, Ukraine
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
Janssen Research & Development, LLCActive, not recruiting
-
University of VirginiaRecruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
University of Alabama at BirminghamActive, not recruitingProstate CancerUnited States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States, France, Poland, Ukraine, United Kingdom, China, Spain, Argentina, Israel, Mexico, Romania, Turkey, Korea, Republic of, Japan, Sweden, Canada, Russian Federation, Brazil, Germany, Hungary, Czechia, Australia
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingProstate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Sir Mortimer B. Davis - Jewish General HospitalRecruitingProstate CancerCanada
-
Medical College of WisconsinCompletedProstate CancerUnited States
-
Astellas Pharma China, Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerChina
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
University of MiamiVarian Medical SystemsNot yet recruiting
-
Janssen Research & Development, LLCActive, not recruitingProstatic NeoplasmsUnited States, Italy, Czechia, Israel, Japan, Taiwan, Korea, Republic of, United Kingdom, France, Spain, Germany, Australia, Canada, Brazil, Netherlands, Russian Federation, Argentina, Poland
-
Novartis PharmaceuticalsCompletedProstate CancerSaudi Arabia, Taiwan, Korea, Republic of, Lebanon, Brazil, China, New Zealand, Australia, Thailand, Kuwait
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm in Lymph Node | Prostate Ductal Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
University of ChicagoNot yet recruiting
-
National Taiwan University HospitalUnknown
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterFerring PharmaceuticalsActive, not recruitingProstate Cancer | Prostatic AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingProstate CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Sohag UniversityNot yet recruiting
-
Samsung Medical CenterActive, not recruiting
-
David VanderWeeleTerminatedCastrate Resistant Prostate CancerUnited States
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong